Pericles Calias
Director de Operaciones en Revolo Biotherapeutics Ltd. .
Perfil
Pericles Calias is currently the Chief Operating Officer at Revolo Biotherapeutics Ltd.
He previously worked as a Scientist at Genzyme Corp., Vice President-Research & Development at Kiora Pharmaceuticals, Inc., Chief Scientific Officer at Pharming Group NV, Vice President-Global CMC & Product Development at Sucampo Pharmaceuticals, Inc., Principal at The Charles Stark Draper Laboratory, Inc., Chief Scientific Officer at to-BBB Holding BV, Chief Scientific Officer at to-BBB technologies BV, and Chief Scientific Officer, Head-R&D at Avalo Therapeutics, Inc. Dr. Calias received his undergraduate degree from Suffolk University and his doctorate from Tufts University.
Cargos activos de Pericles Calias
| Empresas | Cargo | Inicio |
|---|---|---|
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Director de Operaciones | 17/12/2020 |
Antiguos cargos conocidos de Pericles Calias.
| Empresas | Cargo | Fin |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 30/06/2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2018 |
| PHARMING GROUP N.V. | Director Técnico/Científico/I+D | 01/01/2016 |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Director Técnico/Científico/I+D | - |
The Charles Stark Draper Laboratory, Inc.
 The Charles Stark Draper Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services The Charles Stark Draper Laboratory, Inc. engages in the design, development, and deployment of technological solutions. It focuses on the areas of commercial, space, national security, strategic systems, and global challenges. It provides engineering services to government, commercial companies, and educational institutions. The company was founded by Charles Stark Draper in 1934 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Pericles Calias.
| Suffolk University | Undergraduate Degree |
| Tufts University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology to-BBB Holding BV operated as a holding company with interest in providing central nervous system drug technology to the pharmaceutical and biotechnology industries. The firm developed medicines for the treatment of brain diseases. The company was headquartered in The Hague, the Netherlands. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
The Charles Stark Draper Laboratory, Inc.
The Charles Stark Draper Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services The Charles Stark Draper Laboratory, Inc. engages in the design, development, and deployment of technological solutions. It focuses on the areas of commercial, space, national security, strategic systems, and global challenges. It provides engineering services to government, commercial companies, and educational institutions. The company was founded by Charles Stark Draper in 1934 and is headquartered in Cambridge, MA. | Commercial Services |
to-BBB technologies BV
to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Pericles Calias
